Canoroc Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2025.
2025 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Canoroc Pharmaceuticals Private Limited

Canoroc Pharmaceuticals Private Limited, a active private limited company, was established on 20 June 2025 in Mumbai, Maharashtra, India. it holds CIN: U46497MH2025PTC450928. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

Formerly known as Canoroc Pharmaceuticals Private Limited. Its leadership includes Shankar Rajaram Silveri (Director), Anil Jairamdas Rohra (Additional Director), Ramchandra Narayan Sangale (Additional Director). Past directors included Saraswati Shankar Silveri. It is based at 9 Vardhman Warehousing Comp, Plot10 Lbs Marg Nr Surya Nagar, Mumbai, Maharashtra, 400083.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497MH2025PTC450928

  • Registration Number

    450928

  • Incorporation Date

    20 June 2025

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 7 Months 27 Days
Company report

Canoroc Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Canoroc Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Canoroc Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shankar Rajaram Silveri Director 20 Jun 2025 Current
Anil Jairamdas Rohra Additional Director 18 Aug 2025 Current
Ramchandra Narayan Sangale Additional Director 18 Aug 2025 Current
Nagesh Shivajirao Hibare Additional Director 18 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Canoroc Pharmaceuticals.
Canoroc Pharmaceuticals revenue growth over time
Canoroc Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Canoroc Pharmaceuticals?

Unlock access to Canoroc Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Canoroc Pharmaceuticals?

Unlock and access historical data on people associated with Canoroc Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Canoroc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canoroc Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Canoroc Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Anil Jairamdas Rohra was appointed as a Additional Director was appointed as a Additional Director on 18 Aug 2025 & has been associated with this company since 5 months 29 days . was completed.

  • Director Appointment

    Progress on Ramchandra Narayan Sangale was appointed as a Additional Director was appointed as a Additional Director on 18 Aug 2025 & has been associated with this company since 5 months 29 days . was documented.

  • Director Appointment

    The activity Nagesh Shivajirao Hibare was appointed as a Additional Director was appointed as a Additional Director on 18 Aug 2025 & has been associated with this company since 5 months 29 days . was completed.

  • Director Appointment

    The activity Shankar Rajaram Silveri was appointed as a Director was appointed as a Director on 20 Jun 2025 & has been associated with this company since 7 months 27 days . was completed.

  • Company Incorporation

    The activity Canoroc Pharmaceuticals Private Limited was registered on 20 Jun 2025 with Roc Mumbai & aged 7 months 27 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Canoroc Pharmaceuticals Private Limited?

The CIN of Canoroc Pharmaceuticals Private Limited is U46497MH2025PTC450928.

Where is Canoroc Pharmaceuticals Private Limited headquartered?

Canoroc Pharmaceuticals Private Limited is headquartered at 9 Vardhman Warehousing Comp, Plot10 Lbs Marg Nr Surya Nagar, Mumbai, Maharashtra, 400083.

When was Canoroc Pharmaceuticals Private Limited incorporated?

Canoroc Pharmaceuticals Private Limited was incorporated on 20 June 2025.

Who are the current directors of Canoroc Pharmaceuticals Private Limited?

The current directors of Canoroc Pharmaceuticals Private Limited are

Is Canoroc Pharmaceuticals Private Limited a listed company?

Canoroc Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Canoroc Pharmaceuticals Private Limited?

The authorized capital of Canoroc Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available